Company intelligence / Profile preview

AIRA Matrix

Mumbai, Maharashtra, Indiaairamatrix.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

AIRA Matrix has developed a suite of deep learning-based AI solutions that streamline preclinical drug discovery workflows by automating tissue triage/toxicology reporting. Their tools support diagnostic/prognostic/predictive tasks in oncology—especially prostate cancer—and have demonstrated efficiency gains such as reducing reporting cycles from months to weeks. Some product suites are currently undergoing clinical validation with partners in India/the UK/the US.

Therapeutic areas: OncologyPulmonologyOtherGastroenterologyCardiovascularOphthalmology
Modalities: Software
Industry: Drug Discovery Services

Partnerships

GE Edison Accelerator programGE HealthcarehospitalspharmaCROsresearch labs globally

Beyond the preview

Go deeper on AIRA Matrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AIRA Matrix.

Explore the full profile